Thornback JR - Search Results

1

A solid-phase technique for preparation of no-carrier-added technetium-99m radiopharmaceuticals: application to the streptavidin/biotin system.

Dunn-Dufault R, Pollak A, Fitzgerald J, Thornback JR, Ballinger JR. Dunn-Dufault R, et al. Among authors: thornback jr. Nucl Med Biol. 2000 Nov;27(8):803-7. doi: 10.1016/s0969-8051(00)00156-6. Nucl Med Biol. 2000. PMID: 11150714

2

Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology.

Dunn-Dufault R, Pollak A, Thornback JR, Ballinger JR. Dunn-Dufault R, et al. Among authors: thornback jr. Bioconjug Chem. 1999 Sep-Oct;10(5):832-7. doi: 10.1021/bc990032f. Bioconjug Chem. 1999. PMID: 10502350

3

Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicity.

Zhang X, Su ZF, Ballinger JR, Rauth AM, Pollak A, Thornback JR. Zhang X, et al. Among authors: thornback jr. Bioconjug Chem. 2000 May-Jun;11(3):401-7. doi: 10.1021/bc9901595. Bioconjug Chem. 2000. PMID: 10821657

4

Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia.

Su ZF, Zhang X, Ballinger JR, Rauth AM, Pollak A, Thornback JR. Su ZF, et al. Among authors: thornback jr. Bioconjug Chem. 1999 Sep-Oct;10(5):897-904. doi: 10.1021/bc9900542. Bioconjug Chem. 1999. PMID: 10502359

5

Rhenium(V) and Technetium(V) Oxo Complexes of an N(2)N'S Peptidic Chelator: Evidence of Interconversion between the Syn and Anti Conformations.

Wong E, Fauconnier T, Bennett S, Valliant J, Nguyen T, Lau F, Lu LF, Pollak A, Bell RA, Thornback JR. Wong E, et al. Among authors: thornback jr. Inorg Chem. 1997 Dec 3;36(25):5799-5808. doi: 10.1021/ic9706562. Inorg Chem. 1997. PMID: 11670202

6

A new method for labelling of monoclonal antibodies and their fragments with technetium-99m.

Joiris E, Bastin B, Thornback JR. Joiris E, et al. Among authors: thornback jr. Int J Rad Appl Instrum B. 1991;18(3):353-6. doi: 10.1016/0883-2897(91)90131-4. Int J Rad Appl Instrum B. 1991. PMID: 2071447

7

Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.

Van de Wiele C, Dumont F, Vanden Broecke R, Oosterlinck W, Cocquyt V, Serreyn R, Peers S, Thornback J, Slegers G, Dierckx RA. Van de Wiele C, et al. Eur J Nucl Med. 2000 Nov;27(11):1694-9. doi: 10.1007/s002590000355. Eur J Nucl Med. 2000. PMID: 11105826

8

Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study.

Wong E, Bennett S, Lawrence B, Fauconnier T, Lu LF, Bell RA, Thornback JR, Eshima D. Wong E, et al. Among authors: thornback jr. Inorg Chem. 2001 Oct 22;40(22):5695-700. doi: 10.1021/ic010462t. Inorg Chem. 2001. PMID: 11599972 No abstract available.

9

Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.

Gore S, Morris AI, Gilmore IT, Maltby PJ, Thornback JR, Billington D. Gore S, et al. Among authors: thornback jr. J Nucl Med. 1991 Mar;32(3):506-11. J Nucl Med. 1991. PMID: 2005461 Free article.

10

Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.

Van de Wiele C, Dumont F, Dierckx RA, Peers SH, Thornback JR, Slegers G, Thierens H. Van de Wiele C, et al. Among authors: thornback jr. J Nucl Med. 2001 Nov;42(11):1722-7. J Nucl Med. 2001. PMID: 11696645 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters